Half-year report · Q2
2160.TEDINET S100U8GV
Period2024-01-01 → 2024-06-30
Filed2024-08-14
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 62
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥11.7bn | 2024-01-01 → 2024-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥5.8bn | 2024-04-01 → 2024-06-30d | Cons. | Revenue IFRS |
| Revenue | ¥26.0bn | 2023-01-01 → 2023-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥14.1bn | 2023-01-01 → 2023-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥9.9bn | 2023-04-01 → 2023-06-30d | Cons. | Revenue IFRS |
| Operating income | ¥1.8bn | 2024-01-01 → 2024-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | −¥522m | 2024-04-01 → 2024-06-30d | Cons. | Operating profit loss IFRS |
| Operating income | ¥5.5bn | 2023-01-01 → 2023-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥5.1bn | 2023-04-01 → 2023-06-30d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥831m | 2024-01-01 → 2024-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | −¥996m | 2024-04-01 → 2024-06-30d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥12.6bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥5.1bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥5.2bn | 2023-04-01 → 2023-06-30d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥330m | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | −¥1.1bn | 2024-04-01 → 2024-06-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥8.1bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥1.7bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥1.7bn | 2023-04-01 → 2023-06-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | −¥74m | 2024-01-01 → 2024-06-30 | Cons. | Profit loss IFRS |
| Net income | −¥1.4bn | 2024-04-01 → 2024-06-30d | Cons. | Profit loss IFRS |
| Net income | ¥9.5bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥4.0bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥4.4bn | 2023-04-01 → 2023-06-30d | Cons. | Profit loss IFRS |
| Total assets | ¥69.0bn | at 2024-06-30 | Cons. | Assets IFRS |
| Total assets | ¥62.4bn | at 2023-12-31 | Cons. | Assets IFRS |
| Total assets | ¥45.1bn | at 2023-06-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥29.4bn | at 2024-06-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥26.3bn | at 2023-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥39.6bn | at 2024-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥36.1bn | at 2023-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥24.8bn | at 2023-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥19.8bn | at 2022-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥36.8bn | at 2024-06-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥33.8bn | at 2023-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥23.0bn | at 2023-06-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥16.3bn | at 2024-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥21.6bn | at 2023-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥14.1bn | at 2023-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥11.0bn | at 2022-12-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | −¥1.5bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥6.5bn | 2023-01-01 → 2023-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥872m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥5.5bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥6.8bn | 2023-01-01 → 2023-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥2.6bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥186m | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥10.7bn | 2023-01-01 → 2023-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥3.9bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥6.61 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥-22.49 | 2024-04-01 → 2024-06-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥169.5 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥34.93 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥34.99 | 2023-04-01 → 2023-06-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥6.37 | 2024-01-01 → 2024-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥-22.49 | 2024-04-01 → 2024-06-30d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥165.56 | 2023-01-01 → 2023-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥34.81 | 2023-01-01 → 2023-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥34.88 | 2023-04-01 → 2023-06-30d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 53.4% | at 2024-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 54.2% | at 2023-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 51.0% | at 2023-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 22
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E05712-000Medical Devicereportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥2.6bn |
| jpcrp040300-q2r_E05712-000Medical Devicereportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥2.6bn |
| jpcrp040300-q2r_E05712-000Medical Devicereportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥676m |
| jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥9.1bn |
| jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥9.1bn |
| jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥1.1bn |
| —segment total | revenue | 2024-01-01 → 2024-06-30 | ¥11.7bn |
| —segment total | revenue external | 2024-01-01 → 2024-06-30 | ¥11.7bn |
| —segment total | segment profit | 2024-01-01 → 2024-06-30 | ¥1.8bn |
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-06-30 | −¥23m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-06-30 | −¥23m |
| jpcrp040300-q2r_E05712-000Medical Devicereportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥1.4bn |
| jpcrp040300-q2r_E05712-000Medical Devicereportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥1.3bn |
| jpcrp040300-q2r_E05712-000Medical Devicereportable segment | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥23m |
| jpcrp040300-q2r_E05712-000Medical Devicereportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥512m |
| jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥12.8bn |
| jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥12.8bn |
| jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥5.0bn |
| —segment total | revenue | 2023-01-01 → 2023-06-30 | ¥14.1bn |
| —segment total | revenue external | 2023-01-01 → 2023-06-30 | ¥14.1bn |
| —segment total | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥23m |
| —segment total | segment profit | 2023-01-01 → 2023-06-30 | ¥5.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 740
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)太陽有限責任監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)新井 達哉 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)今川 義弘 | |
| Number of submission | FilingDateInstant | 1 | |
| Revenue IFRS (5-year summary) | Prior1YTDDuration | 14096545000 | JPY |
| Revenue IFRS (5-year summary) | CurrentYTDDuration | 11733821000 | JPY |
| Revenue IFRS (5-year summary) | Prior1YearDuration | 26010571000 | JPY |
| Profit loss before tax IFRS (5-year summary) | Prior1YTDDuration | 5117961000 | JPY |
| Profit loss before tax IFRS (5-year summary) | CurrentYTDDuration | 831391000 | JPY |
| Profit loss before tax IFRS (5-year summary) | Prior1YearDuration | 12612748000 | JPY |
| Profit loss IFRS (5-year summary) | Prior1YTDDuration | 4014074000 | JPY |
| Profit loss IFRS (5-year summary) | CurrentYTDDuration | -73850000 | JPY |
| Profit loss IFRS (5-year summary) | Prior1YearDuration | 9504078000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | Prior1YTDDuration | 1658805000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | CurrentYTDDuration | 330126000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | Prior1YearDuration | 8094202000 | JPY |
| Comprehensive income IFRS (5-year summary) | Prior1YTDDuration | 4916349000 | JPY |
| Comprehensive income IFRS (5-year summary) | CurrentYTDDuration | 3278705000 | JPY |
| Comprehensive income IFRS (5-year summary) | Prior1YearDuration | 10662620000 | JPY |
| Comprehensive income attributable to owners of parent IFRS (5-year summary) | Prior1YTDDuration | 2759653000 | JPY |
| Comprehensive income attributable to owners of parent IFRS (5-year summary) | CurrentYTDDuration | 3887790000 | JPY |
| Comprehensive income attributable to owners of parent IFRS (5-year summary) | Prior1YearDuration | 8916299000 | JPY |
| Equity attributable to owners of parent IFRS (5-year summary) | Prior1QuarterInstant | 22976347000 | JPY |
| Equity attributable to owners of parent IFRS (5-year summary) | CurrentQuarterInstant | 36834916000 | JPY |
| Equity attributable to owners of parent IFRS (5-year summary) | Prior1YearInstant | 33794414000 | JPY |
| Total assets IFRS (5-year summary) | Prior1QuarterInstant | 45050897000 | JPY |
| Total assets IFRS (5-year summary) | CurrentQuarterInstant | 68993563000 | JPY |
| Total assets IFRS (5-year summary) | Prior1YearInstant | 62394370000 | JPY |
| Basic earnings loss per share IFRS (5-year summary) | Prior1YTDDuration | 34.93 | |
| Basic earnings loss per share IFRS (5-year summary) | CurrentYTDDuration | 6.61 | |
| Basic earnings loss per share IFRS (5-year summary) | Prior1YearDuration | 169.50 | |
| Diluted earnings loss per share IFRS (5-year summary) | Prior1YTDDuration | 34.81 | |
| Diluted earnings loss per share IFRS (5-year summary) | CurrentYTDDuration | 6.37 | |
| Diluted earnings loss per share IFRS (5-year summary) | Prior1YearDuration | 165.56 | |
| Ratio of owners equity to gross assets IFRS (5-year summary) | Prior1QuarterInstant | 0.510 | |
| Ratio of owners equity to gross assets IFRS (5-year summary) | CurrentQuarterInstant | 0.534 | |
| Ratio of owners equity to gross assets IFRS (5-year summary) | Prior1YearInstant | 0.542 | |
| Cash flows from used in operating activities IFRS (5-year summary) | Prior1YTDDuration | 872378000 | JPY |
| Cash flows from used in operating activities IFRS (5-year summary) | CurrentYTDDuration | -1467673000 | JPY |
| Cash flows from used in operating activities IFRS (5-year summary) | Prior1YearDuration | 6549337000 | JPY |
| Cash flows from used in investing activities IFRS (5-year summary) | Prior1YTDDuration | -2585288000 | JPY |
| Cash flows from used in investing activities IFRS (5-year summary) | CurrentYTDDuration | -5522132000 | JPY |
| Cash flows from used in investing activities IFRS (5-year summary) | Prior1YearDuration | -6842661000 | JPY |
| Cash flows from used in financing activities IFRS (5-year summary) | Prior1YTDDuration | 3942881000 | JPY |
| Cash flows from used in financing activities IFRS (5-year summary) | CurrentYTDDuration | -185598000 | JPY |
| Cash flows from used in financing activities IFRS (5-year summary) | Prior1YearDuration | 10686556000 | JPY |
| Cash and cash equivalents IFRS (5-year summary) | Prior1QuarterInstant | 14076753000 | JPY |
| Cash and cash equivalents IFRS (5-year summary) | CurrentQuarterInstant | 16306208000 | JPY |
| Cash and cash equivalents IFRS (5-year summary) | Prior1YearInstant | 21633028000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |